The Magazine for Sleep Professionals
Tuesday, July 21, 2026
Jazz Pharmaceuticals announced that the company will present 21 abstracts, including 11 late-breaking abstracts, at SLEEP 2026, the 40th annual meeting of the Associated Professional Sleep Societies (APSS), taking place June 14-17, 2026, in Baltimore. The robust breadth of data reflects Jazz’s continued focus on advancing treatment for rare and difficult-to-treat sleep […]
New survey results from the American Academy of Sleep Medicine explore the complex relationship between marijuana use and sleep. One-third (33%) of adults reported that their sleep is slightly or significantly better when they use marijuana. In contrast, 19% of adults reported either no impact (11%) or that their sleep is […]
Over the past 15 years, I have watched sleep medicine evolve through a number of transformative cycles—from lab-dominant diagnostics to home sleep testing (HST), from regional practices to national telemedicine platforms, and from siloed care to increasingly integrated delivery models. Each wave of change has rewardFed organizations that are willing […]
David Josza was recently named Great Lakes new president and chief executive officer. Mr. Josza assumed his new role on May 11, 2026. David Josza has broad experience across the medical and dental device industries. With an MBA in International Finance, he brings proven versatility across start-ups, mid-market companies, and […]
Nihon Kohden announced it is expanding the reach of NomadAir® with Connect — its established at-home sleep apnea diagnostic system — into dental sleep medicine. The company will feature the solution at the American Academy of Dental Sleep Medicine (AADSM) Annual Meeting, taking place May 1–3 in Chicago (Booth 408). The expansion […]
Nexalin Technology, Inc. announced the online publication of a peer-reviewed study in Psychotherapy and Psychosomatics reporting significant clinical improvement and measurable brain-network modulation in patients with chronic insomnia treated with the Company’s high-power 15 mA, 77.5 Hz stimulation approach. The paper was published online on April 20, 2026. The study, titled: “Modulating […]
The rise in GLP-1 medications for weight loss is undeniable. The amount of money Americans spent on GLP-1 medications skyrocketed more than 500% from 2018 to 2023, according to a 2025 study published in JAMA.1 A recent national health tracking poll of 1,350 U.S. adults reported that one in eight […]
Great Lakes Dental Technologies announced an exclusive lab partnership with TAP Sleep Care (Airway Management) to launch the groundbreaking Nylon flexTAP®, the world’s first FDA-cleared, single-point midline digitally printed nylon oral appliance for the treatment of snoring and mild to moderate obstructive sleep apnea (OSA). This strategic collaboration brings together […]
Alkermes plc presents new data from the Vibrance-1 phase 2 study evaluating alixorexton in patients with narcolepsy type 1 (NT1) at the American Academy of Neurology (AAN) 2026 Annual Meeting, taking place April 18-22, 2026 in Chicago. Alixorexton is a novel, investigational, oral, selective orexin 2 receptor (OX2R) agonist in development for the treatment […]
ProSomnus Sleep Technologies announced that the U.S. Food and Drug Administration (FDA) has granted Class II 510(k) clearance for its RPMO₂ OSA Device under the product codes DQA, LQZ, LRK, PLC, and OUG (FDA K252765). The RPMO2 OSA Device is the first theragnostic device for sleep medicine, incorporating both precision […]
